Abstract: Heterocyclic compounds of the formula ##STR1## wherein Het denotes optionally substituted pyridazinyl, pyrimidinyl, pyrazinyl or substituted pyridyl, R.sub.1 is hydrogen or methyl and R.sub.2 is lower alklyl, optionally substituted phenyl-lower alkyl, carboxy-lower alkyl or functionally modified carboxy-lower alkyl, their condensation products with aldehydes, ketones or carbonic acid and their N-oxides, which are valuable (cardioselective) .beta.-receptor blocking agents, and/or (cardioselective) .beta.-receptor-stimulants.

Abstract: Disclosed is a device for dosing light from a light source in accordance with the intensity of light impinging upon a material to be exposed, comprising: a photosensitive element located in the beam path of the light source, comprising a photoresistor having an ohmic resistance inversely proportional to the intensity of light impinging thereon and providing an output voltage; a capacitor arranged in series with the photosensitive element; means, preferably in the form of a switch bridging the capacitor, responsive to switching-on of the light source for initiating charging of the capacitor; switching means arranged in series with said capacitor for varying the charging time thereof, whereby the exposure time of said material to be exposed can be varied by a predetermined ratio to produce a desired shade of gray; optional means for amplifying the output voltage of the photosensitive element; means for comparing the output voltage of the photosensitive element with a reference voltage to produce an output signa

Abstract: A compound of the formula ##STR1## in which R.sub.1 denotes optionally substituted lower alkyl which is optionally branched at the linking carbon atom, R.sub.2 represents hydrogen or lower alkanoyl and R.sub.3 is a group of the formula --R.sub.3.sup.a --(R.sub.3.sup.b).sub.n -- (Ia), in which R.sub.3.sup.a represents the radical of the formula --N(R.sub.4)-- or --O-- and R.sub.4 represents hydrogen or lower alkyl, R.sub.3.sup.b denotes the radical of the formula --CH.sub.2 -- or, if R.sub.3.sup.a represents --N(R.sub.4)--, denotes the radical of the formula --C(.dbd.O)-- and n represents nought or 1, and a group of the formula Ia, in which n represents 1, can be linked to the carbonyl group of the carbamoyl grouping either via the group R.sub.3.sup.a or the group R.sub.3.sup.b, or acid addition salts thereof, which can be used pharmaceutically can be used as beta-receptor blocking agents for the treatment of disorders in the cardiac rhythm and coronary heart diseases.

Abstract: Piperidines of the formula ##STR1## in which R.sub.1 is a substituted or unsubstituted heteroaryl radical, alk.sub.1 and alk.sub.2 independently of one another are lower alkylene radicals, each of which separates by 2 carbon atoms the nitrogen atom bonded thereto from the methane group bonded thereto, R.sub.2 is a free or acylated hydroxyl group, Ph is a substituted or unsubstituted o-phenylene radical, n is 0 or 1, R.sub.3 is a hydrogen atom, a lower alkyl radical or a hydroxyl group and R.sub.5 is a lower alkyl radical or a hydrogen atom, or R.sub.3 and R.sub.5 together are a second bond and R.sub.4 and R.sub.6 are each a hydrogen atom, or R.sub.4 together with R.sub.3 is an oxo group, R.sub.5 is a lower alkyl radical or a hydrogen atom and R.sub.6 is a hydrogen atom, or R.sub.6 together with R.sub.5 is an oxo group, R.sub.3 is a hydrogen atom, a lower alkyl radical or a hydroxyl group and R.sub.4 is a hydrogen atom, or salts thereof are antihypertensive and antiarrhythmic agents.

Abstract: The invention relates to novel piperidino-propanols, especially 1-(3-heterocyclyloxy-2-hydroxy-propanol)-4-(N-diazcyclyl)-piperidines of the formula ##STR1## in which R.sub.1 is a substituted or unsubstituted heteroaryl radical, R.sub.2 is hydrogen or a substituted or unsubstituted aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic hydrocarbon radical or an acyl radical and alk is lower alkylene which separates the two nitrogen atoms from one another by 2 or 3 carbon atoms, or is a substituted or unsubstituted 1,2-phenylene radical, and salts thereof, as well as processes for their preparation, and also to pharmaceutical preparations containing these compounds and the use thereof, preferably in the form of pharmaceutical preparations as antihypertensive agents, antitachycardiac agents and .alpha.-sympathicolytic agents.

Abstract: This invention relates to an improvement in a developing apparatus, especially as part of a photoprinting machine, for developing diazotype copying material capable of being developed by an atmosphere containing gaseous ammonia and water vapor, including a developing chamber comprising at least one first, heated, inclined evaporator trough to which fresh ammonia is adapted to be fed at one side while ammonia water with a reduced ammonia content is adapted to be drained off at the other side, the ammonia water with the reduced ammonia content being adapted to form a pool, and further comprising a siphon through which the ammonia water with the reduced ammonia content and condensate formed in the developing chamber are adapted to be drained off, the improvement that the siphon forms part of an evaporator arranged outside of the developing chamber from which a developer gas pipe leads into the developing chamber, and further comprising a, preferably unheated, reservoir for the ammonia water with the reduced ammo

Abstract: A process known per se for the manufacture of oxygenated N-aryl-diazacyclic compounds of the formula ##STR1## wherein each of R.sub.1 and R.sub.2 represents a substituted or unsubstituted aryl group and alk represents a lower alkylene group which separates both nitrogen atoms from each other by 2 or 3 carbon atoms, or salts thereof.The novel compounds can be used as antihypertensives, antitachycardiac agents and .alpha.-receptor blockers.

Abstract: Heterocyclic compounds of the formula ##STR1## wherein Het denotes optionally substituted pyridazinyl, pyrimidinyl, pyrazinyl or substituted pyridyl, R.sub.1 is hydrogen or methyl and R.sub.2 is lower alkyl, optionally substituted phenyl-lower alkyl, carboxy-lower alkyl or functionally modified carboxy-lower alkyl, their condensation products with aldehydes, ketones or carbonic acid and their N-oxides, which are valuable (cardioselective) .beta.-rezeptor blocking agents, and/or (cardioselective) .beta.-rezeptor-stimulants.

Abstract: The invention is an improvement in an apparatus for developing sheets of diazotype copying material by the semi-dry process and includes at least two rotatable rolls being biased together with a gap between them for passage of the sheets of diazotype material, with an additional force being exerted on at least one of the rolls which force transfers a plane of deflection of one of the rolls to a position outside of a principal plane in which axes of the rolls are located in such a manner that a first line of intersection between the plane of deflection and the shell of the aforesaid one roll, starting from which line of intersection the deflection is directed toward the roll axis, extends in front of the gap, when viewed in the rotational direction of the roll, first guides to bring sheets of diazotype copying material into contact with the roll at a first transition line between the first line of intersection and the gap, and second guides to lift the sheets off of the roll behind the gap at a second transiti

Abstract: A process known per se for the manufacture of oxygenated N-aryl-diazacyclic compounds of the formula ##STR1## wherein EACH OF R.sub.1 and R.sub.2 represents a substituted or unsubstituted aryl group and alk represents a lower alkylene group which separates both nitrogen atoms from each other by 2 or 3 carbon atoms, or salts thereof.The novel compounds can be used as antihypertensives, antitachycardiac agents and .alpha.-receptor blockers.

Abstract: A compound of the formula ##STR1## in which R.sub.1 denotes optionally substituted lower akyl which is optionally branched at the linking carbon atom, R.sub.2 represents hydrogen or lower alkanoyl and R.sub.3 is a group of the formula --R.sub.3.sup.a -(R.sub.3.sup.b).sub.n -- (Ia), in which R.sub.3.sup.1 represents the radical of the formula --N(R.sub.4)-- or --O-- and R.sub.4 represents hydrogen or lower alkyl, R.sub.3.sup.b denotes the radical of the formula --CH.sub.2 -- or, if R.sub.3.sup.a represents --N(R.sub.4)--, denotes the radical of the formula --C(.dbd.O)-- and n represents nought or 1, and a group of the formula Ia, in which n represents 1, can be linked to the carbonyl group of the carbamoyl grouping either via the group R.sub.3.sup.a or the group R.sub.3.sup.b, or acid addition salts thereof, which can be used pharmaceutically can be used as beta-receptor blocking agents for the treatment of disorders in the cardiac rhythm and coronary heart diseases.

Abstract: This invention relates to an improvement in a feeder mechanism at an exposure station of a photoprinting machine, in which a transport device is connected to a first rotary drive for transporting a copying material through the exposure station and in which a second rotary drive is provided which may be operated at variable speeds relative to the speed of the first rotary drive and which is connected to a roller at the beginning of the transport path of an original to be copied, the improvement comprising an additional pair of preceding rollers positioned in the transport path of the original upstream of the transport device in the direction of transport, means connecting said pair of preceding rollers to said variable speed second rotary drive which may be switched in order to drive said pair of preceding rollers optionally at a speed corresponding to the transport speed of the transport device or at a lower speed, switching means in the transport path between said pair of preceding rollers and the transport

Abstract: Compounds of the formula ##STR1## WHEREIN Ar.sub.1 and Ar.sub.2 denote an optionally substituted aromatic hydrocarbon radical or a monocyclic, monoazacyclic or diazacyclic radical of aromatic character and Alk represents lower alkylene, or salts thereof, exhibit .beta.-receptor-blocking, blood pressure-lowering and vasodilatory effects and are useful for example in the treatment of arrythmias and angina pectoris, and as blood pressure-lowering agents.

Abstract: This invention relates to an improvement in the process for the production of photocopies with two-component diazotype material which cannot be developed by the action of heat alone and which, during continuous passage through a photocopying machine, is first exposed imagewise to light emitted by a mercury lamp and is then exposed, for the purpose of development, to an ammonia/water mixture, in vapor form, in a development chamber, the improvement comprising employing light emitted from a gallium-modified or indium-modified mercury lamp for the imagewise exposure of the diazotype material, and exposing the diazotype material, which has been exposed to light, to an ammonia/water vapor mixture in the development chamber, said mixture in terms of vapor pressure being unsaturated and containing at most 25 per cent by weight of ammonia, at a temperature of about 105 to 120.degree. C and at a predetermined pressure. The invention also relates to an apparatus for performing the process.

Abstract: Heterocyclic compounds of the formula ##STR1## wherein Het denotes optionally substituted pyridazinyl, pyrimidinyl, pyrazinyl or substituted pyridyl, R.sub.1 is hydrogen or methyl and R.sub.2 is lower alkyl, optionally substituted phenyl-lower alkyl, carboxy-lower alkyl or functionally modified carboxy-lower alkyl, their condensation products with aldehydes, ketones or carbonic acid and their N-oxides, which are valuable (cardioselective) .beta.-rezeptor blocking agents, and/or (cardioselective) .beta.-rezeptor-stimulants.

Abstract: In a diazo copier, a first developing chamber for developing a diazo material employing an ammonia-containing vaporous developer, a second chamber adjacent an output aperture of the first developing chamber, a source of heat, and a suction device for drawing off developer escaping from the second developing chamber through an output aperture and for removing developer from the diazo material are provided. A rotatably mounted porous hollow roller means forms part of said suction device positioned in said second chamber and a suction duct means is connected to said roller means. A transport means which is not in heat-conducting connection with the source of heat is provided for bringing the copying material in contact with the hollow suction roller means.

Abstract: This invention relates to a developing apparatus for light-sensitive material comprising elongated open trough means, partition means in said trough means dividing said trough means into sections, means providing communication between said sections, inlet and outlet means for said trough means, said inlet means being adapted to introduce solution into one of said sections and said outlet means being adapted to remove solution from another of said sections, heating means in said section containing said outlet means and being positioned below an opening of said outlet means in said trough means, and temperature sensor means connected to said heating means via thermostat means.

Abstract: This invention relates to an improvement in a copying apparatus, particularly a photoprinting apparatus, comprising an exposure station, a developing chamber, and an evaporator associated with the developing chamber, in which a developer composed of an ammonia/water mixture is virtually completely evaporated and over-heated at a temperature about 100.degree. C, preferably about 105.degree. C, and at a predetermined pressure, preferably atmospheric pressure, the apparatus further including, for dosage of the ammonia/water mixture, a feed pipe connected with the evaporator, a valve connected with the feed pipe, and a control unit connected with the valve, whereby the rate of feed of the ammonia/water mixture may be adapted to different operating conditions, the improvement comprising first switch means, actuatable by an original, positioned at an entrance for the original upstream of an exposure station in the feed direction of the apparatus.

Abstract: This invention relates to a method of exposure control in photographic printing apparatus for printing from originals made on different types of photographic material, the method comprising:Determining which of at least two types (such as silver halide or diazo film) of photographic material the original employs by an examination of the spectral transmission characteristics of the original,Determining the image density of the original, andControlling the exposure in accordance with both the type of material as determined and the image density.

Abstract: In a photoprinting machine including a developing chamber in which a web of exposed diazotype paper continuously fed at an adjustable speed is developed with a developer medium composed of a vaporous ammonia/water mixture, an after-treating chamber following next in the direction of feed of the diazotype paper and which is connected with a device for removing ammonia-containing exhaust air, and a device for expelling developer medium from the developed diazotype paper. The expelling device includes a high energy infrared radiator positioned opposite the web in the after-treating chamber, a connection between the high-energy infrared radiator and an output of a heat output control device, and an input for the heat control device connected to a transmitter of the feed speed. The heat output control device having a characteristic such that the heat output of the high-energy infrared radiator is proportional to the feed speed and the color temperature of the high-energy infrared radiator is about 2000.degree.